Changes in heart rate variability and QT variability during the first trimester of pregnancy by Dareyoush, Rassi & Michael, Lewis
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
Physiological Measurement
                                        
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa21301
_____________________________________________________________
 
Paper:
Lewis, M. (2015).  Changes in Heart Rate Variability and QT Variability during the First Trimester of Pregnancy.
Physiological Measurement
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
  
 
Changes in Heart Rate Variability and QT Variability during the First 
Trimester of Pregnancy 
RE Carpenter1, LA D’Silva1, SJ Emery2, O Uzun3, D Rassi4, MJ Lewis1* 
1College of Engineering, Swansea University, Swansea, UK 
2Department of Gynaecology, Singleton Hospital, Swansea, UK 
3Department of Paediatric Cardiology, University Hospital of Wales, Cardiff, UK 
4College of Health and Human Sciences, Swansea University, Swansea, UK 
 
*Corresponding author address: 
College of Engineering 
Swansea University 
Talbot Building  
Singleton Park 
Swansea 
SA2 8PP 
Tel. +44 1792 513043 
Email. m.j.lewis@swansea.ac.uk 
 
Keywords: Heart rate variability, QT variability, Pregnancy, Arrhythmia, Autonomic nervous system 
 
 
Short Title: Early Cardiovascular Changes during Pregnancy 
  
 
 
Abstract 
The risk of new-onset arrhythmia during pregnancy is high, presumably relating to changes 
in both haemodynamic and cardiac autonomic function. The ability to non-invasively assess 
an individual’s risk of developing arrhythmia during pregnancy would therefore be clinically 
significant. We aimed to quantify electrocardiographic temporal characteristics during the 
first trimester of pregnancy and to compare these with non-pregnant controls.  
Ninety-nine pregnant women and sixty-three non-pregnant women underwent non-invasive 
cardiovascular and haemodynamic assessment during a protocol consisting of various 
physiological states (postural manoeurvres, light exercise and metronomic breathing). 
Variables measured included stroke volume, cardiac output, heart rate, heart rate 
variability, QT and QT variability and QTVI (a measure of the variability of QT relative to that 
of RR). 
Heart rate (p<0.0005, p<0.0005, p<0.0005) and cardiac output (p=0.043, p<0.0005, 
p<0.0005) were greater in pregnant women in all physiological states (respectively for the 
supine position, light exercise and metronomic breathing state), whilst stroke volume was 
lower in pregnancy only during the supine position (p<0.0005). QTe (Q wave onset to T 
wave end) and QTa (T wave apex) were significantly shortened (p<0.05) and QTeVI and 
QTaVI were increased in pregnancy in all physiological states (p<0.0005). QT variability 
(p<0.002) was greater in pregnant women during the supine position, whilst heart rate 
variability was reduced in pregnancy in all states (p<0.0005).   
Early pregnancy is associated with substantial changes in heart rate variability, reflecting a 
reduction in parasympathetic tone and an increase in sympathetic activity. QTVI shifted to a 
less favourable value, reflecting a greater than normal amount of QT variability. QTVI 
appears to be a useful method for quantifying changes in QT variability relative to RR (or 
heart rate) variability, being sensitive not only to physiological state but also to gestational 
age.  We support the use of non-invasive markers of cardiac electrical variability to evaluate 
the risk of arrhythmic events in pregnancy, and we recommend the use of multiple 
physiological states during the assessment protocol. 
  
 
 
1. Introduction 
Women tend to have higher intrinsic heart rates (Jose & Collison, 1970) and more prolonged 
QT intervals (Molnar et al., 1996) compared with men. Some cardiac arrhythmias are also 
more prevalent in women, such as the increased incidence of supraventricular tachycardias 
(SVT) (Porter et al., 2004). The risk of new onset SVT is further elevated during normal 
pregnancy (Kron & Conti, 2007) with 24 per 100,000 pregnancies experiencing SVT (Li et al., 
2008), as is the incidence of symptomatic ectopic activity, with up to 50% of pregnant 
women experiencing non-sustained ventricular arrhythmias at some point during their 
pregnancy (Kron & Conti, 2007). The incidence of pregnancy-induced arrhythmia appears to 
be uniform throughout pregnancy with perhaps an increased frequency during late 
pregnancy (Shotan et al., 1997; Nakagawa et al., 2004), although information on this is 
limited. This elevated incidence is presumably related to changes in both cardiac autonomic 
function (for supraventricular events) and in ion channel conduction (for ventricular events) 
within the myocardium. Pregnancy is also associated with substantial haemodynamic 
changes, which can cause myocardial stretching and may thus promote arrhythmogenic 
events (Kanoupakis & Vardas, 2005; Adamson & Nelson-Piercy, 2007). The ability to non-
invasively assess (and act upon) an individual’s risk of developing arrhythmia during 
pregnancy would therefore be clinically significant. 
Changes in autonomic activity during pregnancy are poorly documented (Kuo et al., 2000). 
The general consensus is that heart rate variability (HRV, a surrogate marker of cardiac 
autonomic control that describes beat-to-beat variation in cardiac (RR) interval) decreases 
with advancing gestation (Speranza et al., 1998; Kuo et al., 2000; Chamchad et al., 2007). 
However, these findings are mainly based on measurements taken during late pregnancy 
and then compared with non-pregnant controls. The extent of changes in cardiac autonomic 
function during earlier stages of pregnancy is not known, but marked increases in 
sympathetic activity have been observed in other body systems within the first few weeks of 
conception (Jarvis et al., 2012). Clearly a comprehensive description of normal cardiac 
autonomic changes from the earliest stages of pregnancy would be necessary in the context 
of developing a biomarker of antenatal arrhythmogenic risk (Nakagawa et al., 2004).  
 
 
The QT interval is a measure of ventricular depolarisation and repolarisation within the 
cardiac cycle, which is strongly influenced by heart rate as well other chronotropic factors. 
The QT interval has not been extensively studied during pregnancy. QT interval shortens 
during the second-half of pregnancy and remains reduced for up to three days post-partum, 
reflecting its heart rate-dependence (Baumert et al., 2010). The QT variability index (QTVI; 
Berger et al., (1997)) extends the concept of HRV to a comparison of the relative 
magnitudes of temporal variability within the electrocardiographic RR and QT intervals. 
QTVI is a good indicator of elevated risk for ventricular arrhythmic events – for example, 
QTVI is associated with an independent risk for ventricular tachycardia or ventricular 
fibrillation events (Haigney et al., 2004). QTVI has not been assessed during pregnancy, 
although Baumert et al. (2010) observed that QT variability is higher by late pregnancy (post 
28 weeks gestation) in comparison with non-pregnant women. 
The aim of this study was to quantify changes in RR and QT variabilities (including QTVI) 
during relatively early stages of pregnancy (the end of the first trimester) in the context of 
assessing their use as possible biomarkers for antenatal maternal arrhythmia risk. 
 
2. Method 
2.1 Participants 
2.1.1 Non-pregnant: Eligible participants were women aged between 18 and 40 years, were 
not pregnant at the time of measurement, and had no history of cardiovascular or chronic 
respiratory disease, sleep apnoea or central or peripheral nervous system disorders. Written 
informed consent was taken at the initial meeting and participants were provided with a 
participant information sheet. Ethical approval was obtained from the College of 
Engineering’s Applied Sport and Technology Exercise and Medicine (A-STEM) Ethics 
Committee and all procedures were conducted in accordance with the Declaration of 
Helsinki. 
2.1.2 Pregnant: Eligible participants were apparently healthy pregnant women aged 18 
years or over, with no existing complications of pregnancy at their 12-week dating scan.  
Participants were recruited via a number of methods (via direct contact at the antenatal 
 
 
clinic, strategically placed posters, advertisements in local newspapers and via email). 
Exclusion criteria were: a history of cardiovascular or chronic respiratory problems, sleep 
apnoea, or a central/peripheral nervous system disorder.  Recruited participants were 
provided with details about the study, including practical requirements and potential risks, 
and were given one week to consider whether they wished to take part. Individuals who 
wanted to participate gave their written consent. Participants were informed that they were 
free to leave the study at any time and this would not affect their standard antenatal care. 
Ethical approval was obtained from the local (South West Wales) Research Ethics 
Committee and all procedures were conducted in accordance with the Declaration of 
Helsinki. 
2.2 Physiological measurements 
HRV can be quantified reproducibly during rest and exercise (McNarry & Lewis, 2012) and 
our previous observations indicate that this is also generally true for beat-to-beat 
haemodynamic variables (D'Silva et al., 2014). Consequently single physiological 
assessments were considered appropriate at each defined stage of the assessment 
schedule. Physiological monitoring was carried out on four occasions for pregnant 
participants: at 12-16, 24 -26 and 34-36 weeks gestational age, corresponding to the end of 
the three trimesters (T1, T2, T3) and also at 12-weeks post-partum (PP).  Non-pregnant 
participants underwent physiological assessment on one occasion only. All participants were 
asked to perform a series of postural manoeuvres and various interventions designed to 
provoke changes in the cardiovascular and autonomic nervous systems. Participants were 
asked to refrain from drinking tea, coffee, alcohol or a heavy meal within 2 hours prior to 
assessment and to not exercise within 24 hours prior to assessment. 
2.2.1 Experimental protocol: Participants were first asked to lie in a 45o reclined-supine 
position for six minutes, after which they were asked to stand for the same duration.  
Participants then performed a light stepping exercise for six minutes, using the Nintendo Wii 
games console and ‘balance board’ platform (to provide a visual stimulus for exercise).  This 
was followed by a six minute seated recovery period.  Participants then undertook a three 
minute cognitive test in the seated position (to provoke a sympathetic autonomic response), 
during which they were asked to repeatedly subtract the number seventeen from a four 
 
 
digit number.  The arithmetic test was carried out in the participant’s head (they did not 
need to give a verbal answer). Participants then breathed in time to a metronome for three 
minutes at a rate of 20 breaths per minute (designed to initiate a parasympathetic 
response) and then to return to their normal (spontaneous) breathing pattern for three 
minutes.  The total duration of the measurement protocol was thirty-three minutes. 
2.2.2 Physiological variables quantified: Participants underwent continuous Holter ECG 
monitoring (Pathfinder/Lifecard Digital system; Spacelabs Medical Ltd., UK), providing ECG 
data with a 1024 Hz sampling frequency. The ECG recordings were assessed for quality by 
human observation using the Pathfinder system, primarily to verify the absence of excessive 
noise or artefact. Beat-to-beat cardiac interval (RR) was measured automatically by the 
Pathfinder system (using a proprietary algorithm) and visually assessed to identify and 
delete any obvious artefacts (which occurred infrequently, with less than 0.1% of beats 
edited in this way). Heart rate variability (HRV) was quantified in terms of RMSSD (square 
root of the mean squared differences in successive RR intervals), SDRR (standard deviation 
of the RR intervals), LF (low frequency power), HF (high frequency power), VLF (very low 
frequency power), LFn (normalised low-frequency component), HFn (normalised high-
frequency component) and Total Power.  
QTe (Q wave onset to T wave end), QTa (Q wave onset to T wave apex) and RR intervals 
were measured for each sinus beat and exported for further analysis using the Reynolds 
Research Tools software (Del Mar Reynolds Medical Ltd., UK). QTeVI and QTaVI were 
calculated according to the equation described by Berger et al (1997):  
QTVI = Log10[(QTv/QTm2)/(RRv/RRm2)] 
where QTv and RRv are the variabilities of QT and RR, respectively, and QTm and RRm are 
the mean values of these parameters for each deﬁned period.  
RMSSDQT (square root of the mean squared differences in successive QT intervals) and 
SDQT (standard deviation of the QT intervals) were also calculated. The Task Force 
Haemodynamic monitor (CNSystems Medizintechnik GMBH, Austria) recorded beat-to-beat 
cardiovascular performance via impedance cardiography (transthoracic bioelectrical 
impedance analysis) and beat-to-beat systolic and diastolic blood pressures (SBP, DBP) via 
 
 
vascular unloading photoplethysmography. The following variables were also determined; 
heart rate (HR), stroke volume (SV), cardiac output (CO), total peripheral resistance (TPR), 
compliance, stiffness, left ventricular ejection time (LVET) & end diastolic index (EDI).  
2.3 Statistical Analysis 
Normality of the data was assessed using the Kolmogorov-Smirnov test. Independent 
samples t-tests were used to assess between group differences at each stage of the 
protocol. Data are presented for the non-pregnant participants (NP) and for the first 
antenatal measurement (T1). Results for the gestational changes will be presented 
elsewhere. Statistical significance was accepted as p<0.05. All data are presented as Mean ± 
SEM (standard error of the mean).  
 
3. Results 
3.1 Participant characteristics 
Ninety-nine pregnant women completed the first antenatal measurement (T1) at a mean 
gestational age of 15.1 ± 1.7 weeks and sixty-three non-pregnant participants were 
assessed. Participant characteristics are displayed in Table 1. 49.5% of pregnant women 
were nulliparous and 50.5% primiparous or multiparous. 
Table 1. Participant characteristics (mean ± SD) 
 
Non-pregnant 
(n=63) 
T1 
(n=99) 
Age (years) 23.5 ± 5.6 29.1 ± 4.9 
Height (cm) 167.1 ± 6.7 164.0 ± 5.3 
Weight (kg) 63.9 ± 9.8 68.8 ± 14.1 
BMI (kg·m-2) 22.9 ± 2.9 25.6 ± 5.2 
 
3.2 Haemodynamics 
Figure 1 compares the HR, SV, CO and SBP for pregnant and non-pregnant groups during the 
supine, exercise and metronomic breathing states. In summary: (1) HR (p<0.0005, p<0.0005, 
p<0.0005 respectively for physiological state) and CO (p=0.043, p<0.0005, p<0.0005) were 
 
 
significantly greater in pregnant women than in non-pregnant controls in all three states; (2) 
SV was lower during pregnancy but only in the supine position (p<0.0005); (3) TPR was 
lower during pregnancy in all states (p=0.004, p<0.0005, p<0.0005); (4) Blood pressure 
(MBP, SBP, DBP) (p=0.010, p=0.008, p=0.011) and EDI (p<0.001) were significantly reduced 
in pregnancy only during metronomic breathing; (5) Compliance (p=0.001), EDI (p<0.0005) 
and LVET (p<0.0005) were all reduced in pregnancy but only in the supine position (Table 2). 
a.)  
 
b.)  
 
c.)  
 
d.)  
 
* Statistically different from non-pregnant values. 
Figure 1. Haemodynamic variables during the supine, exercise and metronomic breathing states for pregnant 
and non-pregnant groups. Box plots display the median and upper/lower quartiles of the data, whilst the 
whiskers show the maximum and minimum values. Solid boxes represent non-pregnant participants and 
shaded bars represent pregnant participants.  
* 
* 
* * 
* 
* 
* 
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3.3 QT Variability 
Figure 2 compares QTe, RMSSDQTe, SDQTe and QTeVI for pregnant and non-pregnant 
groups during the supine, exercise and metronomic breathing states. All QTa variables can 
be found in Table 3. In summary: (1) QTe and QTa were significantly shortened in pregnant 
women than in non-pregnant controls in the supine position (p<0.0005, p<0.0005), during 
exercise (p=0.013, p=0.012) and during metronomic breathing (p=0.001, p=0.001); (2) QTeVI 
and QTaVI were significantly increased (became less negative) with pregnancy in all 
physiological states (p<0.0005); (3) RMSSDQTe and SDQTe were significantly greater in 
pregnant women than in non-pregnant controls but only in the supine position (p<0.0005, 
p=0.002); (4) RMSSDQTa was greater in the supine posture (p=0.009) and reduced during 
exercise (p<0.0005) (Table 3).  
 
3.4 Heart Rate Variability 
Figure 3 compares the RMSSD, SDRR, HFn, LFn and Total Power for pregnant and non-
pregnant groups during the supine, exercise and metronomic breathing states. In summary: 
(1) RR (p<0.0005), RMSSD (p<0.0005), SDRR (p<0.0005), Total Power (p<0.0005, p=0.014, 
p<0.0005), HF (p<0.0005, p=0.002, p<0.0005), and LF (p<0.0005) (Table 4) were lower in 
pregnant women than in non-pregnant controls in all three states; (2) LFn was higher during 
pregnancy but only in the supine position (p<0.0005); (3) HFn and VLF were lower during 
pregnancy in the supine position (p<0.0005, p<0.0005 respectively) and during metronomic 
breathing (p=0.015, p<0.0005 respectively) (Table 4). 
  
 
 
a.)  
 
b.)  
 
c.) 
 
d.)  
 
* Statistically different from non-pregnant values. 
 
Figure 2. QT variables during supine, exercise and metronomic breathing states for pregnant and non-pregnant 
groups. Box plots display the median and upper/lower quartiles of the data, whilst the whiskers show the 
maximum and minimum values. Solid boxes represent non-pregnant participants and shaded bars represent 
pregnant participants.  
* * * * 
* 
* 
* 
* 
 
 
* Statistically different from non-pregnant values. 
Figure 3. Heart Rate Variability variables during the supine, exercise and metronomic breathing states for 
pregnant and non-pregnant groups. Box plots display the median and upper/lower quartiles of the data, whilst 
the whiskers show the maximum and minimum values. Solid boxes represent non-pregnant participants and 
shaded bars represent pregnant participants.  
a.) 
 
b.)  
 
c.) 
 
d.) 
 
 
e.) 
 
 
* 
* 
* * * 
* 
* 
* 
* 
* 
* 
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Table 2. Haemodynamic variables during the supine, exercise and metronomic breathing states for pregnant 
and non-pregnant groups (mean ± SEM).  
 Supine Exercise Metronomic Breathing 
 NP T1 p NP T1 p NP T1 p 
HR (bpm) 65.5± 1.3 83.0 ± 1.0 * 91.6 ± 1.4 103.8 ± 1.3 * 75.1 ± 1.5 84.1 ± 1.1 * 
SV (ml) 101.4 ± 2.4 86.2 ±1.5 * 93.4 ± 2.0 93.2 ± 1.3 0.924 88.7 ± 2.0 85.9 ± 1.1 0.228 
CO (L·min-1) 6.6 ± 0.2 7.1 ± 0.1 0.043 8.5 ± 0.2 9.6 ± 0.1 * 6.6 ± 0.1 7.2 ± 0.1 * 
TPR 
(dyn.sec.cm-5) 
1025 ± 32 915 ± 18 0.004 839 ± 21 721 ± 13 * 1047 ± 23 906 ± 15 * 
Compliance 
(ml·mmHg-1) 
2.6 ± 0.1 2.3 ± 0.05 0.001 2.2 ± 0.1 2.0 ± 0.05 0.107 2.1 ± 0.1 2.2 ± 0.04 0.608 
Stiffness 
(mmHg·ml-1) 
0.4 ± 0.01 0.5 ± 0.01 0.001 0.5 ± 0.02 0.5 ± 0.01 0.105 0.5 ± 0.01 0.5 ± 0.01 0.608 
SBP (mmHg) 111.5 ± 1.3 108.5 ± 1.0 0.065 117.5 ± 2.2 118.9 ± 1.6 0.524 115.2 ± 1.4 110.4 ± 1.2 0.008 
DBP (mmHg) 71.0 ± 1.0 69.8 ± 0.8 0.345 71.7 ± 1.4 70.4 ± 1.1 0.454 72.8 ± 1.0 69.6 ± 0.9 0.011 
MBP (mmHg) 83.0 ± 1.1 81.5 ± 0.9 0.299 87.1 ± 1.6 86.6 ± 1.2 0.807 86.2 ± 1.1 82.5 ± 1.0 0.010 
LVET (ms) 319.4 ± 2.1 290.2 ± 1.8 * 271.0 ± 2.0 255.3 ± 1.6 * 287.6 ± 2.9 282.9 ± 2.0 0.169 
EDI (ml·m-2) 93.9 ± 1.9 79.8 ± 1.3 * 92.9 ± 1.4 91.2 ± 1.1 0.350 88.5 ± 1.5 82.3 ± 1.1 0.001 
 
* p < 5x10-4 
 
 
Table 3. QT variables during the supine, exercise and metronomic breathing states pregnant and non-pregnant 
groups (mean ± SEM). 
 
 Supine Exercise Metronomic Breathing 
 NP T1 p NP T1 p NP T1 p 
QTe (ms) 376.4 ± 3.8 346.3 ± 2.3 * 347.2 ± 3.3 337.3 ± 2.2 0.013 358.9 ± 3.9 344.4 ± 2.3 0.001 
QTeVI -1.4 ± 0.04 -0.9 ± 0.03 * -0.7 ± 0.04 -0.4 ± 0.03 * -1.1 ± 0.05  -0.8 ± 0.04 * 
RMSSDQTe (ms) 8.9 ± 0.4 10.6 ± 0.2 * 12.6 ± 0.2 12.3 ± 0.2 0.322 9.2 ± 0.4 9.9 ± 0.3 0.120 
SDQTe (ms) 7.4 ± 0.3 8.4 ± 0.2 0.002 9.8 ± 0.2 10.1 ± 0.1 0.053 7.2 ± 0.3 7.5 ± 0.2 0.361 
QTa (ms) 312.4 ± 3.5 284.5 ± 2.1 * 286.7 ± 2.7 278.3 ± 1.9 0.012 295.8 ± 3.5 282.7 ± 2.1 0.001 
QTaVI -1.3 ± 0.04 -0.9 ± 0.03 * -0.7 ± 0.04 -0.4 ± 0.03 * -1.0 ± 0.04 -0.7 ± 0.03 * 
RMSSDQTa (ms) 8.6 ± 0.2 9.3 ± 0.2 0.009 10.6 ± 0.2 9.8 ± 0.1 * 9.5 ± 0.2 9.3 ± 0.2 0.475 
SDQTa (ms) 6.8 ± 0.2 7.2 ± 0.2 0.065 8.3 ± 0.1 8.4 ± 0.1 0.481 7.1 ± 0.2 7.0 ± 0.2 0.564 
 
* p < 5x10-4 
  
 
 
Table 4. Heart rate variability indices during the supine, exercise and metronomic breathing states pregnant 
and non-pregnant groups (mean ± SEM). 
 
 Supine Exercise Metronomic Breathing 
 NP T1 p NP T1 p NP T1 p 
RMSSD (ms) 77.0 ± 6.3 29.9 ± 1.5 * 28.3 ± 1.6 19.3 ± 0.9 * 53.4 ± 3.7 29.5 ± 1.5 * 
SDRR (ms) 83.9 ± 4.4 44.3 ± 1.6 * 51.9 ± 2.5 39.5 ± 1.6 * 73.0 ± 4.2 50.2 ± 2.1 * 
RR (ms) 951.6 ± 20.6 733.0 ± 8.7 * 710.5 ± 11.3 622.2 ± 7.4 * 833.8 ± 19.3 683.4 ± 9.5 * 
HFn 0.44 ± 0.01 0.37 ± 0.01 * 0.32 ± 0.01 0.31 ± 0.01 0.317 0.40 ± 0.01 0.37 ± 0.01 0.015 
LFn 0.38 ± 0.01 0.43 ± 0.01 * 0.49 ± 0.01 0.49 ± 0.01 0.817 0.42 ± 0.01 0.43 ± 0.01 0.582 
Total Power 
(ms2) 
146.0 ± 4.4 106.4 ± 1.9 * 111.3 ± 2.3 104.2 ± 1.9 0.014 121.9 ± 3.2 99.3 ± 1.7 * 
HF (ms2) 14.9 ± 1.1 6.9 ± 0.4 * 5.7 ± 0.3 4.5 ± 0.2 0.002 10.5 ± 0.7 7.0 ± 0.4 * 
LF (ms2) 12.5 ± 0.8 7.8 ± 0.3 * 8.9 ± 0.5 7.0 ± 0.3 * 11.0 ± 0.8 7.9 ± 0.4 * 
VLF (ms2) 112.4 ± 2.7 88.1 ± 1.6 * 93.4 ± 1.9 89.3 ± 1.6 0.073 95.7 ± 2.1 80.7 ± 1.1 * 
 
* p < 5x10-4 
 
 
4. Discussion 
We measured cardiac performance indices continuously during a protocol consisting of 
various standardised physiological states, thus providing a comprehensive characterisation 
of cardiovascular and haemodynamic responses to ‘early’ pregnancy. The main findings 
were that, compared with non-pregnant values, early pregnancy is associated with (1) 
increased heart rate and cardiac output in all physiological states, (2) decreased stroke 
volume but only in the supine position, (3) shortening of QTe and QTa intervals in all 
physiological states, (4) increases in QTeVI and QTaVI in all physiological states, (5) increases 
in RMSSDQTe and SDQTe only in the supine position, and (6) reductions in RMSSD, SDRR,  
and HFn in all states.   
Previous studies have strongly debated the time course of haemodynamic changes during 
early pregnancy (Capeless & Clapp, 1989; Duvekot et al., 1993).  We therefore also 
measured haemodynamic changes, allowing us to characterise the influence of our protocol 
on conventional measures of cardiovascular performance. We observed (1) an increase in 
heart rate and a decrease in stroke volume in the supine position (suggesting that at this 
stage of pregnancy heart rate is the predominant mechanism for increasing cardiac output), 
(2) a reduction in total peripheral resistance (TPR) during pregnancy in all states, (3) a 
reduction in end diastolic volume index (EDI) during the supine posture and in response to 
 
 
metronomic breathing, (4) a reduction in left ventricular ejection time (LVET) in the supine 
posture and exercise state, and (5) a reduction in blood pressure in pregnancy but only 
during metronomic breathing. Consistent with our findings, Duvekot et al. (1993) found an 
increase in cardiac output, caused by a rise in heart rate, by the tenth week of gestation. 
Similarly, Capeless & Clapp (1989) found a rise in cardiac output by 8 weeks gestation in 
comparison to pre-conception values; however this rise was predominantly as a result of 
increased stroke volume as opposed to heart rate. In contrast to our results Mahendru et al. 
(2014) found no increase in cardiac output, despite an increase in heart rate at 6 weeks 
gestation. The early time point at which this measurement was taken may be the reason for 
this difference. Our observation of a reduction in TPR is also consistent with other authors 
(Duvekot et al., 1993; San-Frutos et al., 2011). The reduction in blood pressure observed 
during metronomic breathing may be associated with a reduction in parasympathetic 
activity with pregnancy.  
Baumert at al. (2010) have previously found that QT interval is shortened by the second half 
of pregnancy (post 28 weeks) in comparison to non-pregnant controls but they found no 
changes at earlier gestational ages. These authors also observed that rate-corrected QT 
(QTc) was not changed by pregnancy and so concluded that the duration of ventricular 
repolarisation is entirely rate-dependent. Gondoni et al. (2011) found a strong relationship 
between ejection fraction and QTc and since it is well documented that ejection fraction is 
unaltered with pregnancy (Capeless & Clapp, 1989), this may explain the unaltered QTc with 
gestation. We have extended these observations by showing that uncorrected QTe and QTa 
are significantly reduced even by the end of the first trimester and notably in all 
physiological states. This suggests that pregnant women are able to maintain cardiac 
repolarisation at a safe level, during rest and light exercise, without exposing them to high 
risk arrhythmia. We did not separately assess rate-corrected QT as our objective here was to 
examine QT variability and (using QTVI) the relative magnitudes of QT and RR variabilities.   
The HRV indices RMSSD, SDRR and HFn were all reduced during pregnancy, whilst LFn 
increased. Notably HFn was reduced in both the supine and metronomic breathing states, 
both of which are associated with dominant parasympathetic control. Thus these changes in 
HRV appear to reflect a substantial reduction in parasympathetic tone and an increase in 
sympathetic activity by the end of the first trimester of pregnancy.  Sympathetic activity has 
 
 
previously been noted to increase by late pregnancy (measured using HRV) (Speranza et al., 
1998; Kuo et al., 2000; Voss et al., 2000), with sympathetic hyperactivity at this stage 
indicating an increased risk of hypertension and pre-eclampsia (Greenwood et al., 2003) but 
its relative influence during early pregnancy has not been convincingly determined. Jarvis et 
al. (2012) observed marked increases in systemic sympathetic neural activity within the first 
weeks of conception (via muscle sympathetic neural activation). Conversely, Kuo et al. 
(1997) reported a higher vagal and a lower sympathetic modulation in three different 
recumbent positions (in particular the supine position) during pregnancy.  An increase in 
baseline (supine) sympathetic activity during the early stages of pregnancy might have 
advantageous effects as it enhances the ability of pregnant women to adapt to 
haemodynamic changes and thus reduces the risk of orthostatic hypotension upon standing. 
Interestingly, LFn (a surrogate measure of sympathetic activity) was the same for both 
pregnant and non-pregnant women during light exercise, despite a further increase in 
cardiac output in the pregnant participants. This suggests that light exercise poses no 
increased risk to women during the early stages of pregnancy. Further longitudinal 
characterisations of HRV are therefore required to clarify the dynamics of cardiac autonomic 
control during pregnancy. 
Whether these observed alterations in autonomic control of heart rate (supraventricular 
influences) also influence ventricular myocardial repolarisation (i.e. QT interval duration and 
variability) is yet to be clearly determined. Myocardial repolarisation might be influenced by 
pathological, physiological or other structural changes in the heart, or by autonomic neural 
activity changes (Piccirillo et al., 2007). Using an analogous approach to the time-domain 
assessment of HRV we assessed QT variability in terms of two statistical measures: 
RMSSDQTe and SDQTe. We found that in the supine position QT variability was increased by 
the end of the first trimester in comparison to non-pregnant controls, whilst no changes 
were seen during exercise or metronomic breathing states. It might be speculated that the 
autonomic nervous system could influence ventricular repolarisation independently of the 
sino-atrial node, considering the observed reduction in parasympathetic activity during the 
first trimester, as studies have shown parasympathetic withdrawal to have an important 
influence on the shortening of the QT interval at higher heart rates during exercise 
(Magnano et al., 2002) and therefore the same mechanism might be relevant to the 
 
 
physiological changes during pregnancy. However ventricular repolarisation is thought to be 
predominantly controlled by the beta-adrenergic system and any vagal effects are indirect 
and secondary to changes in heart rate (Can et al., 2002). Advancing gestation is also 
associated with hypervolaemia, leading to structural changes in the left ventricle. These 
changes may alter specific regions and layers of the ventricular tissue thus altering ion 
channel activity.  
The QT variability index (QTVI), first proposed by Berger et al. (1997), describes the relative 
magnitude of temporal variability in myocardial depolarisation and repolarisation phases. It 
has been suggested that QTVI can be used to quantify the relative autonomic influences on 
the atrial and ventricular myocardium during rest and exercise, and that it might reflect the 
balance between heart rate-dependent and heart rate-independent influences on the QT 
interval (Lewis & Short, 2008). Previously an increase in QTVI has been associated with a 
greater susceptibility to ventricular arrhythmias and sudden death (Berger et al., 1997; Atiga 
et al., 2000). However, ours is the first study to investigate the influence of pregnancy on 
QTVI. We found that QTVI was elevated as a result of early physiological changes associated 
with pregnancy in all physiological states. QTVI was highest during exercise in both the 
pregnant and non-pregnant women, further increased in the pregnant women. This increase 
in QTVI suggests that QT variability is more predominant over changes in RR variability at 
this time, indicative of a parasympathetic shift in the sympatho-vagal balance with 
pregnancy. As pregnancy is associated with an increase in arrhythmogenic events (Siu et al., 
2001; Nakagawa et al., 2004; Li et al., 2008) the use of QTVI as a potential biomarker for 
screening patients at such an early stage might be of great clinical importance. QTVI is 
known to be further increased with exercise (Lewis et al., 2006; Lewis & Short, 2008). At 
moderate intensities of exercise Lewis et al. (2006) reported a progressive increase in QTVI 
with work rate. Healthy non-pregnant individuals typically have a QTVI value of around -1 or 
lower at rest: Dobson et al. (2013) reported a mean QTVI of -1.34 in 173 healthy volunteers 
(unpublished data). Consistent with Dobson et al. (2013) we noted non-pregnant values of -
1.4 and -1.3 (for QTeVI and QTaVI respectively) but higher values of around -0.9 in pregnant 
women. Despite increased values with pregnancy, at no point did QTVI become positive or 
exceed a value of 0.1, a value proposed as a discriminator for higher risk of arrhythmogenic 
events (Atiga et al., 1998). This indicates that QT variability is not markedly influenced by 
 
 
pregnancy during the first trimester, suggesting that it is unlikely to be the cause of the 
increased risk of arrhythmia in pregnancy. It remains to be seen whether QTVI increases 
further during later gestation, and more work is needed to evaluate whether QT variability 
might be the cause of increased arrhythmia susceptibility during that stage of pregnancy. 
Our study has shown that QTVI is a sensitive marker of not only physiological state but also 
of gestational age and therefore its use to determine arrhythmogenic events in normal and 
abnormal pregnancy should be considered. Using QTVI as a marker of arrhythmogenic 
activity during pregnancy might enable non-invasive assessment of the need for anti-
arrhythmic treatment as well as quantifying the influence of lifestyle factors such as exercise 
on cardiac electrical function.  
 
Limitations 
We used late first trimester/early second trimester values as a baseline measure to 
characterise the extent of cardiovascular changes within ‘early’ pregnancy. Ideally we would 
have recruited women prior to conception because it is known that physiological changes 
are evident as early as the sixth week of gestation, and this would have enabled a true 
assessment of ‘early’ pregnancy changes. However, owing to time constraints and a specific 
period of funding for our work this was not feasible in the present study. We did not assess 
heart rate-corrected QT and were thus not able to comment on the likely determinants of 
QT interval shortening at this early stage of pregnancy.  
 
Conclusion 
The early stages of pregnancy are associated with substantial changes in cardiac autonomic 
control, with reductions in parasympathetic tone and increases in sympathetic activity. 
Whether these changes influence ventricular myocardial repolarisation and thus predispose 
women to arrhythmogenic events is yet to be determined. We have shown that QTVI is a 
sensitive marker of not only physiological state but also of gestational age. The use of QTVI 
as a marker of arrhythmia risk during pregnancy is feasible and could provide clinically 
important information regarding the need for prophylactic anti-arrhythmia treatment. We 
 
 
have used unique and novel concepts to assess cardiovascular responses to early pregnancy. 
These non-invasive methods have great clinical potential in predicting and identifying 
normal and abnormal responses to increased physiological stress, such as occur during 
orthostatic manoeuvre and light intensity exercise. 
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